BLONDEAUX, EVA
 Distribuzione geografica
Continente #
EU - Europa 2.310
AS - Asia 452
NA - Nord America 420
Continente sconosciuto - Info sul continente non disponibili 108
SA - Sud America 41
AF - Africa 6
OC - Oceania 1
Totale 3.338
Nazione #
IT - Italia 2.237
US - Stati Uniti d'America 384
SG - Singapore 162
CN - Cina 101
VN - Vietnam 78
BD - Bangladesh 69
BR - Brasile 20
FR - Francia 17
HK - Hong Kong 15
DE - Germania 13
CA - Canada 12
FI - Finlandia 9
MX - Messico 7
AR - Argentina 6
EC - Ecuador 5
IN - India 5
JM - Giamaica 5
JP - Giappone 5
CH - Svizzera 4
GB - Regno Unito 4
AT - Austria 3
CO - Colombia 3
HN - Honduras 3
IQ - Iraq 3
NL - Olanda 3
PY - Paraguay 3
RO - Romania 3
UA - Ucraina 3
ZA - Sudafrica 3
BE - Belgio 2
CR - Costa Rica 2
EG - Egitto 2
GT - Guatemala 2
ID - Indonesia 2
MY - Malesia 2
OM - Oman 2
PH - Filippine 2
RU - Federazione Russa 2
SE - Svezia 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
GY - Guiana 1
IE - Irlanda 1
JO - Giordania 1
LB - Libano 1
MD - Moldavia 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 3.230
Città #
Genova 921
Genoa 832
Rapallo 219
Vado Ligure 159
Singapore 86
San Jose 79
Ashburn 70
Ho Chi Minh City 25
Beijing 20
Hanoi 18
Bordighera 17
Hong Kong 15
Council Bluffs 14
Lauterbourg 14
Santa Clara 14
New York 13
Buffalo 9
Boardman 8
Helsinki 8
Naples 8
Frankfurt am Main 7
Los Angeles 7
Milan 6
Bologna 5
Da Nang 5
Mexico City 5
São Paulo 5
Tokyo 5
Boston 4
Kingston 4
Muggia 4
Philadelphia 4
Queens 4
Rome 4
Tianjin 4
Toronto 4
Cleveland 3
Florence 3
Hải Dương 3
Louisville 3
Miami 3
Seattle 3
Stuttgart 3
Verona 3
Afragola 2
Alessandria 2
Amsterdam 2
Asunción 2
Augusta 2
Biên Hòa 2
Brussels 2
Catania 2
Chicago 2
Clinton 2
Dallas 2
Dayton 2
Detroit 2
Haiphong 2
Hamilton 2
Haverhill 2
Hayward 2
Houston 2
Inglewood 2
Lakewood 2
Las Vegas 2
Montreal 2
Muscat 2
Nashville 2
Nuremberg 2
Oberglatt 2
Orem 2
Parma 2
Phủ Lý 2
Riobamba 2
Rochester 2
San José 2
San Pedro Sula 2
Shanghai 2
Stockholm 2
Surrey 2
Taranto 2
Troy 2
Venice 2
Vienna 2
Villasanta 2
Vitória da Conquista 2
Washington 2
Waterbury 2
Zurich 2
Alabaster 1
Albert Lea 1
Allentown 1
Amherst 1
Angeles City 1
Araripe 1
Atlanta 1
Bandar Lampung 1
Barranquilla 1
Beaumont 1
Bekasi 1
Totale 2.751
Nome #
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 208
Management of young women with early breast cancer 192
PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy 183
The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients 179
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 177
News on the medical treatment of young women with early-stage HER2-negative breast cancer 167
Treatment with aromatase inhibitors and markers of cardiovascular disease 166
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 165
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 151
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer 149
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 143
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer 139
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 132
Role of dose-dense chemotherapy in high-risk early breast cancer 128
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network 111
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 107
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition 101
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer 95
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 87
Immunotherapy for resectable NSCLC: neoadjuvant/perioperative followed by surgery over surgery followed by adjuvant. Systematic review and meta-analysis with subgroup analyses 83
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials 83
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study 69
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies 57
Response to Venkataraman and Mokbel 56
ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY 54
Breastfeeding after breast cancer in young BRCA carriers 35
Fertility and ovarian function preservation in young women with breast cancer: A joint analysis of the Joven & Fuerte and PREFER prospective studies 31
End‑of‑life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center 28
null 27
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis 21
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial 7
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEX 7
Totale 3.338
Categoria #
all - tutte 11.380
article - articoli 11.380
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022196 4 7 5 31 8 20 11 37 22 20 7 24
2022/2023250 20 25 1 30 47 38 2 19 35 4 28 1
2023/2024189 4 12 3 28 12 18 18 13 9 16 15 41
2024/2025510 23 25 14 30 47 50 33 115 29 28 62 54
2025/20261.277 120 28 74 106 177 58 158 65 97 146 101 147
2026/2027127 127 0 0 0 0 0 0 0 0 0 0 0
Totale 3.338